Get started
Work

SWOG‐9510: evaluation of topotecan in hormone refractory prostate cancer: A southwest oncology group study

Year: 2002
Type: article
Study design: Clinical Trial
Source: The Prostate
DOI: 10.1002/pros.10118
Authors: Catherine E. Klein, Catherine M. Tangen, Thomas J. Braun, Maha H.A. Hussain, David M. Peereboom, Craig R. Nichols, Saul E. Rivkin, Shaker R. Dakhil, E. David Crawford
Institutions: University of Colorado Denver, SWOG Cancer Research Network, Wayne State University, Cleveland Clinic, Oregon Health & Science University, Fred Hutch Cancer Center, National Institutes of Health
Language: English
Field: Medicine
Open Access status: closed
Awards: Southwest Oncology Group, G1202672505, G1279808231, G1469275664, G1549000524, COOPERATIVE STUDY OF CANCER CHEMOTHERAPY, G1799289401, G1911575068, G1958973285, G2064543036, G2745671310, Southwest Oncology Group U10 Member Site, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, G345775953, G425646771, Southwest Oncology Group, G4292856267, G5504618518, G6109875642, Southwest Oncology Group Treatment Grant, SOUTHWEST ONCOLOGY GROUP, NORTHWEST COMMUNITY CLINICAL ONCOLOGY PROGRAM, CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM, Hawaii Minority-Based Clinical Community Oncology Program, Community Clinical Oncology Program, Development of a Registry for Familial Pancreatic Cancer, G791413246, SOUTHWEST ONCOLOGY GROUP (UTAH), SOUTHWEST ONCOLOGY GROUP, G960417071
OpenAlex ID: W2113523500
FWCI: 1.304
Cites: 19
Cited by: 10
Related to: 10